Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.

Escherich, Gabriele

Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. [electronic resource] - Pediatric blood & cancer Feb 2013 - 254-7 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

1545-5017

10.1002/pbc.24273 doi


Adolescent
Antineoplastic Agents--therapeutic use
Child
Child, Preschool
Daunorubicin--therapeutic use
Disease-Free Survival
Doxorubicin--therapeutic use
Female
Humans
Infant
Kaplan-Meier Estimate
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy